Which Drug Class Account for the Largest Share of Biosimilars Industry?

I recently came across a report by Roots Analysis that really put things into perspective. According to them, The global biosimilars market, valued at USD 28.0 billion in 2025 , is projected to reach USD 32.3 billion in 2026 and USD 130.1 billion by 2035 , representing a CAGR of 16.7% during the forecast period 2026 to 2035.

The research highlights general factors that may be contributing to market expansion, offering a neutral and data-focused view. The Biosimilars Market forecast is based on the analysis of available information, without assigning speculative cause-and-effect reasoning to specific trends.